Gilead Sciences's market cap is currently ―. The company's EPS TTM is $0.358; its P/E ratio is 179.18; and it has a dividend yield of 4.71%. Gilead Sciences is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $1.59. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 7.11B	$ 7.05B	$ 6.56B	$ 6.31B	$ 7.39B
Gross Profit	$ 5.02B	$ 5.49B	$ 5.16B	$ 4.95B	$ 5.99B
EBIT	$ 1.91B	$ 2.55B	$ 1.82B	$ 1.53B	$ 2.26B
EBITDA	$ 2.59B	$ 3.23B	$ 2.50B	$ 2.17B	$ 2.79B
Net Income Common Stockholders	$ 1.43B	$ 2.18B	$ 1.04B	$ 1.01B	$ 1.64B
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 1.18B	$ 1.16B	$ 6.67B	$ 5.87B	$ 6.38B
Total Assets	$ 62.13B	$ 62.37B	$ 62.34B	$ 61.88B	$ 63.17B
Total Debt	$ 24.99B	$ 24.98B	$ 25.25B	$ 25.24B	$ 25.23B
Net Debt	$ 23.81B	$ 23.82B	$ 18.58B	$ 19.37B	$ 18.84B
Total Liabilities	$ 39.38B	$ 40.13B	$ 41.24B	$ 40.94B	$ 41.96B
Stockholders Equity	$ 22.83B	$ 22.31B	$ 21.16B	$ 21.00B	$ 21.24B
Cash Flow	-
Free Cash Flow	$ 1.95B	$ 2.35B	$ 1.48B	$ 1.64B	$ 2.39B
Operating Cash Flow	$ 2.17B	$ 2.47B	$ 1.62B	$ 1.75B	$ 2.57B
Investing Cash Flow	$ -727.00M	$ -229.00M	$ -483.00M	$ -826.00M	$ -375.00M
Financing Cash Flow	$ -1.10B	$ -2.24B	$ -383.00M	$ -1.41B	$ -1.55B

Currency in USD

Gilead Sciences Earnings and Revenue History

Income Statement >

Gilead Sciences Debt to Assets

Balance Sheet >

Gilead Sciences Cash Flow

Cash Flow >

Gilead Sciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing